Cadila Healthcare informs about disclosure

23 Sep 2021 Evaluate
Cadila Healthcare has informed that it enclosed disclosure in prescribed Form C under Regulation 7[2] of SEBI [Prohibition of Insider Trading] Regulations, 2015, received from Nitin Parekh, Chief Financial Officer of the Company with respect to sale of 10,000 Equity Shares of Re 1 each in the open market.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

948.20 -2.75 (-0.29%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.